Intracellular Cytokine Staining

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, Kurt Miller, Wolfgang Schultze-Seemann, Frank vom Dorp, Giorgio Parmiani, Christian Hampel, Steffen Wedel, Lutz Trojan, Dieter Jocham, Tobias Maurer, Gerd Rippin, Mariola Fotin-Mleczek, Florian von der Mülbe, Jochen Probst, Ingmar Hoerr, Karl-Josef Kallen, Thomas Lander, Arnulf Stenzl

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 26; DOI: 10.1186/s40425-015-0068-y
CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function
Fuliang Chu, Sattva S Neelapu

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P321; DOI: 10.1186/2051-1426-3-S2-P321
Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy
Junko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, Hiroshi Shiku, Junichi Mineno, Sachiko Okamoto, Lloyd Old, Protul Shrikant, Sacha Gnjatic, Kunle Odunsi

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P34; DOI: 10.1186/2051-1426-3-S2-P34
Rapid expansion of TILs from patients with glioma and recognition of autologous tumor
Liu Zhenjiang, Qingda Meng, Oscar Persson, Bartek Jiri, Thomas Poiret, Lalit Rane, Elena B Rangelova, Ernest Dodoo, Markus Maeurer

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P27; DOI: 10.1186/2051-1426-2-S3-P27
A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive^®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part
Sven D Koch, Henoch Hong, Susan Feyerabend, Margitta Retz, Hubert Kuebler, Axel Heidenreich, Thomas van Erps, Andreas Schroeder, Birgit Scheel, Valérie Reus, Karl-Josef Kallen, Mariola Fotin-Mleczek, Ulrike Gnad-Vogt, Arnulf Stenzl

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P85; DOI: 10.1186/2051-1426-2-S3-P85
Use of high throughput T cell receptor (TCR) DNA sequencing to characterize T cell infusion products and track clonal expansion in vivo
Madeleine Strohl, Hallie Graor, Mei Zhang, Isabelle Rivers-McCue, John Ammori, Julian Kim

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P143; DOI: 10.1186/2051-1426-2-S3-P143
A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes
Craig L Slingluff, Gina R Petroni, Walter C Olson, Kimberly A Chianese-bullock, Kelly T Smith, Mark E Smolkin, Nadedja Galeassi, William Grosh, Geoffrey Weiss, Kristy Scott, Ana Hornillo

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P60; DOI: 10.1186/2051-1426-2-S3-P60
Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells
Ernest Dodoo, Liu zhenjiang, Bartek Jiri, Oscar Persson, Qingda Meng, Thomas Poiret, Lalit Rane, Christopher Illies, Julia Karbach, Elke Jäger, Markus Maeurer

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P24; DOI: 10.1186/2051-1426-2-S3-P24
A pilot study of Ipilimumab in patients with stage IV melanoma receiving palliative radiation therapy
Susan Knox, Sunil Reddy, Susan M Hiniker, Susan Swetter, Lei Shura, Holden T Maecker

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P75; DOI: 10.1186/2051-1426-2-S3-P75
P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
K Krebs, K Metzger, L Weigand, C Dargel, E Kieback, W Uckert, D Busch, A Krackhardt, U Protzer

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P47; DOI: 10.1186/2051-1426-2-S2-P47

Log in using your username and password

Main menu

Log in using your username and password

You are here

Intracellular Cytokine Staining